Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 245
Filter
1.
Hematol., Transfus. Cell Ther. (Impr.) ; 46(1): 8-13, Jan.-Mar. 2024. tab, graf
Article in English | LILACS | ID: biblio-1557890

ABSTRACT

Abstract Objective The purpose of this study was to evaluate the clinical-epidemiological profile, associated risk factors and clinical outcomes of patients with acute myeloid leukemia (AML), identifying the main causes of morbidity and mortality and overall survival rate of patients at five years of follow-up. Method This was a retrospective cohort study evaluating the prognosis and clinical outcomes of 222 patients diagnosed with AML at three large hematology centers in Ceará (northeastern Brazil) over a period of five years. Results The mean age at diagnosis was 44.1 ± 16 years, with a female prevalence of 1.3:1. No additional relevant risk factors associated with the development of AML were found, except for the well-established cytogenetic assessment. The overall 5-year survival rate was 39.4% (95%CI: 35.47 - 42.17). The main causes of death were disease progression (37.72%; n = 84) and sepsis (31.58%; n = 70). Conclusion The clinical outcomes in our sample of AML patients were similar to those of other reported groups. Disease progression and infection were the main causes of death. Access to diagnostic flow cytometry and karyotyping was greater in our sample than in the national average. As expected, overall survival differed significantly according to the risk, as determined by cytogenetic testing.


Subject(s)
Leukemia, Myeloid, Acute , Prognosis , Leukemia
2.
Journal of Clinical Surgery ; (12): 148-152, 2024.
Article in Chinese | WPRIM | ID: wpr-1019308

ABSTRACT

Objective To investigate the predictive value of urinary exosomal microRNA(miR)-29 c in the clinical outcome of organ-and non-organ-confined bladder urothelial carcinoma(BUC).Methods From January 2017 to March 2022,152 patients with BUC were recruited from the Department of Urology in our hospital as a validation set.In addition,126 non-cancer controls were selected from the physical examination center of our hospital.The expression level of urinary exosomal miR-29c was detected by real-time quantitative PCR.Results In the validation set,urinary exosomal miR-29c level in BUC patients was significantly lower than that in non-cancer control group(P<0.05),while urinary exosomal miR-17-5p level and miR-590-5p level were not significantly different(P>0.05).The area under ROC curve of urinary exosomal miR-29c for the diagnosis of BUC was 0.969(95%CI:0.953~0.986),and the corresponding sensitivity and specificity were 92.1%and 90.2%,respectively.In subtype analysis,urinary exosomal miR-29c levels were further reduced in patients with non-organ-confined BUC compared with patients with organ-confined BUC(P=0.009).Overall survival(OS),disease-free survival(DFS)and disease-specific survival(DSS)were longer in the urinary exosomal miR-29c high expression group(P<0.05).Conclusion Low levels of urinary exosomal miR-29c are an adverse prognostic factor for survival in patients with BUC,and are promising as a predictor of adverse clinical outcomes of organ-and non-organ-confined BUC.

3.
Article in English | WPRIM | ID: wpr-1011014

ABSTRACT

As the search for effective treatments for COVID-19 continues, the high mortality rate among critically ill patients in Intensive Care Units (ICU) presents a profound challenge. This study explores the potential benefits of traditional Chinese medicine (TCM) as a supplementary treatment for severe COVID-19. A total of 110 critically ill COVID-19 patients at the Intensive Care Unit (ICU) of Vulcan Hill Hospital between Feb., 2020, and April, 2020 (Wuhan, China) participated in this observational study. All patients received standard supportive care protocols, with a subset of 81 also receiving TCM as an adjunct treatment. Clinical characteristics during the treatment period and the clinical outcome of each patient were closely monitored and analysed. Our findings indicated that the TCM group exhibited a significantly lower mortality rate compared with the non-TCM group (16 of 81 vs 24 of 29; 0.3 vs 2.3 person/month). In the adjusted Cox proportional hazards models, TCM treatment was associated with improved survival odds (P < 0.001). Furthermore, the analysis also revealed that TCM treatment could partially mitigate inflammatory responses, as evidenced by the reduced levels of proinflammatory cytokines, and contribute to the recovery of multiple organic functions, thereby potentially increasing the survival rate of critically ill COVID-19 patients.


Subject(s)
Humans , COVID-19 , Medicine, Chinese Traditional , SARS-CoV-2 , Critical Illness , Treatment Outcome
4.
Article in English | WPRIM | ID: wpr-1013424

ABSTRACT

Objective@#This study sought to define the profile and outcome of Covid-19 in adult patients with renal insufficiency admitted to the Bicol Regional Training and Teaching Hospital (BRTTH) from March 1, 2020, to February 28, 2021.@*Methods@#Retrospective cross-sectional study and utilized descriptive statistics.@*Results@#A total of 49 patients who tested positive for Covid- 19 also had renal insufficiency. The included patients were aged 51 to 60 (26.5%) and 61 to 70 (26.5%) years old, almost equal in sex distribution. Majority were unemployed (81.6%). On clinical profile most have no history of smoking (85.7%), alcohol intake (81.6%), and drug illicit use (100%). Predominantly the eGFR level was less than 15 mL/min (89.8%), with diabetes mellitus (36.7%) as the leading cause of renal insufficiency, followed by hypertension (61.2%). Majority received hemodialysis (81.6%) and advised for the continuation of hemodialysis (51%) upon discharge. Their length of stay was from 0-5 days (30.6%) with most being admitted to the intensive care unit (55.1%). Most were eventually discharged (63.3%).@*Conclusion@#Patients admitted in this hospital who had Covid-19 and renal insufficiency were between 51-70 years old, almost equally divided between males and females, and unemployed. Majority denied smoking, alcohol intake, and drug illicit use. The average eGFR was less than 15 mL/min, had diabetes mellitus and hypertension as a co-morbidity. The treatment received upon admission consisted mostly of hemodialysis only. Their length of hospital stay was 0-5 days with most being admitted to the ICU. Majority of the patients were eventually discharged.


Subject(s)
COVID-19 , Renal Insufficiency
5.
Article in English | LILACS-Express | LILACS | ID: biblio-1535304

ABSTRACT

ABSTRACT Hepatitis C virus (HCV) infection is a significant cause of morbidity and mortality among hematopoietic stem cell transplant (HCT) recipients. In Brazil, its occurrence in HCT recipients remains undetermined. We now report on HCV prevalence in HCT recipients and its clinical consequences. The medical records of all HCT recipients seen at Hospital das Clinicas, Sao Paulo University Medical School, from January 2010 to January 2020 were reviewed to determine HCV serostatus. A retrospective analysis of medical charts was undertaken on all seropositive cases to determine HCV genotype, presence of liver fibrosis, co-infections with other viruses, previous treatments, and clinical evolution of liver pathology after HCT. Of the 1,293 HCT recipients included in the study, seven (0.54%) were HCV antibody-positive and five (0.39%) were also viremic for HCV-RNA. Four of these individuals had moderate to severe liver fibrosis (METAVIR F2/F3) and one was cirrhotic. Two of the viremic patients developed acute liver dysfunction following transplantation. All patients had their acute episode of liver dysfunction resolved with no further complications. Four of the viremic patients were treated for HCV infection with direct acting agents (DAA). Information regarding HCV treatment was lacking for one of the viremic HCV patients due to loss of follow up. Sustained anti-virologic responses were observed in three cases after the use of DAA. The detection of HCV in hematological adults undergoing HCT and its successful treatment with DAA highlight the necessity of testing for HCV both prior to and following transplantation.

6.
Rev. bras. cir. cardiovasc ; Rev. bras. cir. cardiovasc;39(4): e20230438, 2024. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1569617

ABSTRACT

ABSTRACT Objectives: The aims of the present study were to compare the long-term outcomes for ascending aortic dilatation and adverse aortic events after isolated aortic valve replacement between patients with bicuspid aortic valve (BAV) and tricuspid aortic valve ( TAV). Methods: This retrospective study included 310 patients who had undergone isolated aortic valve replacement with an ascending aorta diameter ≤ 45 mm between January 2010 and September 2021. The patients were divided into BAV group (n=90) and TAV group (n=220). The differences in the dilation rate of the ascending aorta and long-term outcomes were analyzed. Results: Overall survival was 89 ± 4% in the BAV group vs. 75 ± 6% in the TAV group at 10 years postoperatively (P=0.007), yet this difference disappeared after adjusting exclusively for age (P=0.343). The mean annual growth rate of the ascending aorta was similar between the two groups during follow-up (0.5 ± 0.6 mm/year vs. 0.4 ± 0.5 mm/year; P=0.498). Ten-year freedom from adverse aortic events was 98.1% in the BAV group vs. 95.0% in the TAV group (P=0.636). Multivariable analysis revealed preoperative ascending aorta diameter to be a significant predictor of adverse aortic events (hazard ratio: 1.76; 95% confidence interval: 1.33 to 2.38; P<0.001). Conclusion: Our study revealed that the long-term survival and the risks of adverse aortic events between BAV and TAV patients were similar after isolated aortic valve replacement. BAV was not a risk factor of adverse aortic events.

7.
Article | IMSEAR | ID: sea-220163

ABSTRACT

Background: Neovascular age-related macular degeneration (nAMD), also known as wet AMD, is a chronic eye disease that affects the macula, which is the central part of the retina responsible for sharp, central vision. Brolucizumab is a type of anti-vascular endothelial growth factor (VEGF) drug, which works by blocking the activity of a protein called VEGF that promotes the growth of abnormal blood vessels under the macula in neovascular AMD. The aim of this study was to evaluate the clinical outcome of brolucizumab in the treatment of neovascular age-related macular degeneration. Material & Methods: This prospective observational study was conducted in Department of Ophthalmology, Bangladesh Eye Hospital & Institute Ltd, Dhaka, Bangladesh, during the period from February 2022 to February 2023. Total 60 patients with neovascular AMD were included in this study who were treated with brolucizumab. Results: The mean age of the patients was 74.3 (SD±9.8) years. Majority of the study subjects were (51.7%) female patients in the study. In our study, majority (38.3%) of the patients had only their right eye affected. In optical coherence tomography (OCT) findings, we found that a high percentage of patients had subretinal fluid (85%), intraretinal fluid (61.7%), and sub-RPE fluid (83.3%). The BCVA showed a significant change after 12 weeks of treatment, as indicated by the P-value of 0.0007. Here improvement of vision was seen in patients with AMD with active Choroidal neovascularization (CNV). But in case of AMD with macular scar, no improvement of vision was seen. In addition, the SRT, FCP, and CMT parameters also showed a statistically significant (P<0.001) improvement after brolucizumab treatment. In our study, 4 patients (6.7%) experienced intraocular inflammation, which is inflammation within the eye, 2 patients (3.3%) reported cloudy vision, and 3 patients (5%) experienced eye redness as a complication of the treatment. The majority of the patients, 51 (85%) did not experience any complications from the treatment. After treatment, improved vision was seen in most of the study patients (70%) and 30% had no improvement. Conclusion: From the findings of our study, it can be concluded that brolucizumab may be an effective treatment for neovascular AMD, as it can improve the best-corrected visual acuity and structural outcomes of the retina such as subfoveal retinal thickness, foveal center point, and central macular thickness. There was also a tolerable complication rate after treatment.

8.
Chinese Journal of Hepatology ; (12): 705-709, 2023.
Article in Chinese | WPRIM | ID: wpr-986198

ABSTRACT

Objective: To investigate the clinical features and long-term prognosis of primary biliary cholangitis (PBC) in patients with past hepatitis B virus (HBV) infection. Methods: 353 cases with PBC who visited the Liver Disease Center of Beijing Friendship Hospital Affiliated to Capital Medical University between January 2000 and January 2018 were retrospectively analyzed and were divided into the past HBV infection group (156 cases) and the no HBV infection group (197 cases). The two groups' baseline clinical features were compared. Ursodeoxycholic acid response rate after one year, GLOBE score, UK-PBC score, and long-term liver transplantation-free survival rate were compared through outpatient and telephone follow-up. Results: PBC with past HBV infection had a significantly reduced female proportion compared to the no HBV infection group (91.9% vs. 79.5%, P = 0.001). However, there were no statistically significant differences in age, biochemical indices, immunological indicators, platelet count, cirrhosis proportion, and others. Ursodeoxycholic acid biochemical response rate was reduced in patients with past HBV infection at the end of one year of treatment, but the difference was not statistically significant (65.8% vs. 78.2%, P = 0.068). In addition, there were no statistically significant differences between the GLOBE score (0.57 vs. 0.59, P = 0.26) and UK-PBC 5-year (2.87% vs. 2.87%, P = 0.38), 10-year (9.29% vs. 8.2%, P = 0.39) and 15-year liver transplantation rates (16.6% vs. 14.73%, P = 0.39). Lastly, the overall 5-year liver transplantation-free survival rate had no statistically significant difference between the two groups of patients (86.4% vs. 87.5%, P = 0.796). Conclusion: Primary biliary cholangitis had no discernible effect in terms of age at onset, biochemical indices, immunological indicators, cirrhosis proportion, ursodeoxycholic acid response rate after one year, GLOBE score, UK-PBC score, or overall liver transplantation-free survival rate in patients with past hepatitis B virus infections.

9.
Chinese Circulation Journal ; (12): 1239-1245, 2023.
Article in Chinese | WPRIM | ID: wpr-1025421

ABSTRACT

Objectives:To analyze the impact of target lesion calcification evaluated by coronary angiography on immediate procedure success rate and long-term clinical outcome in patients underwent percutaneous coronary intervention(PCI). Methods:Consecutive patients received angiographic calcification evaluation and underwent PCI in Fuwai Hospital,Chinese Academy of Medical Sciences from January 2017 to December 2018 were prospectively enrolled in this study.Patients are divided into 4 groups,including non-calcification group(n=14 387),mild calcification group(n=8 231),moderate calcification group(n=3 208)and severe calcification group(n=886).The primary endpoint was immediate post-PCI procedure success rate,which was defined as residual stenosis<50%without major operational complications(including coronary artery perforation,coronary artery dissection,intraoperative stent thrombosis)and failure to cross the lesion.The long-term clinical endpoint was the 3-year major adverse cardiovascular events(MACE),which included composite endpoint events such as all cause death,myocardial infarction(MI),and revascularization. Results:The severe calcification group had a lower success rate of interventional therapy(80.59%vs.94.23%vs.94.29%vs.91.49%),a higher incidence of residual stenosis≥50%(17.72%vs.5.03%vs.4.84%vs.7.29%),a higher incidence of coronary artery dissection(1.81%vs.0.66%vs.0.78%vs.1.25%),and a higher incidence of coronary artery perforation(2.14%vs.0.51%vs.0.38%vs.0.69%),and a higher incidence of failure to cross the lesion(0.23%vs.0.12%vs.0.04%vs.0.16%)compared to the non-calcification group,mild calcification group,and moderate calcification group(all P<0.05).Multivariate Cox regression analysis showed that patients with severe calcification had a higher risk of MACE(12.98%vs.9.35%,HR=1.21,95%CI:1.00-1.47,P=0.046),all-cause mortality(4.29%vs.1.80%,HR=1.55,95%CI:1.10-2.18,P=0.013),and MI(2.14%vs.0.97%,HR=1.97,95%CI:1.21-3.20,P=0.006)compared to patients without calcification. Conclusions:Patients with angiographic-detected severe calcification after PCI treatment face higher risk of PCI procedure failure,MACE,all-cause death,and MI compared to patients without,with mild,and moderate calcification.

10.
Article in Chinese | WPRIM | ID: wpr-1020088

ABSTRACT

Objective:To compare the effect of luteal-phase support administration of gonadotrophin-releasing hormone agonist(GnRH-a)on the outcomes of fresh embryo transfer in GnRH antagonist cycles,and explore a more appropriate protocol of luteal-phase support.Methods:A retrospective analysis was performed on the infer-tility patients who receiving in vitro fertilization or intracytoplasmic sperm injection embryo transfer(IVF/ICSI-ET)in the Reproductive Medicine Center of our hospital from January 2018 to December 2021.Our study collected clini-cal data from 674 cycles of infertility patients undergoing fresh cycle transplantation using antagonist regimens.The patients were divided into the control group(n =348)and the observation group(n =326)according to if Gn-RH-a was added to the luteal phase.The patients in control group were given standard luteal support treatment,while the patients in observation group were given multiple-dose GnRH-a 0.1mg to standard luteal support treat-ment after egg retrieval.The general data,ovulation induction and clinical outcome were compared between the two groups.Results:Between the two groups of patients,there was no statistically significant difference in age,years of infertility,body mass index(BMI),basal follicle stimulating hormone(bFSH),days and total amount of gonadotropin(Gn),chorionic gonadotropin(HCG),luteinizing hormone(LH),estradiol(E2)and progesterone(P),the number of retrieved oocytes,MII oocytes,number of embryos,normal fertilization rate,moderate to se-vere ovarian hyperstimulation syndrome(OHSS)rate,abortion rate,live birth rate,multiple pregnancy rate,inci-dence of pregnancy complications,birth weight of offspring,preterm birth rate,and birth defect rate(P>0.05).The implantation rate and clinical pregnancy rate were significantly higher in the observation group compared with control group(P<0.05).Multivariate Logistic regression analysis indicated that age and number of transferred embryos could influence the clinical pregnancy rate(OR 0.958,95%CI 0.917-1.000;OR 1.857,95%CI 1.173-2.942).Conclusions:In fresh embryo transfer cycles with GnRH antagonist protocol,on the basis of conventional luteal support,multi-dose intermittent short-acting GnRH-a for luteal support can achieve a good clin-ical outcome,and may be a suitable luteal support scheme for GnRH antagonist protocol in fresh embryo transfer cycles.

11.
Article in Chinese | WPRIM | ID: wpr-990419

ABSTRACT

Objective:To investigate the current sedation level of patients with mechanical ventilation in ICU, and to explore the influence of early different sedation levels on clinical outcomes, so as to provide theoretical basis for better guidance of clinical sedation evaluation and implementation of sedation strategy management.Methods:This study was a retrospective longitudinal study. The 201 patients with invasive mechanical ventilation who underwent sedation in the Department of Intensive Care Medicine of the First Affiliated Hospital of Guangxi Medical University from January to December 2021 were selected by convenience sampling method. According to the results of Richmond Agitation-Sedation Scale(RASS), the patients were divided into deep sedation group (98 cases) and shallow sedation group (103 cases). The influencing factors of endotracheal intubation retention time and outcome were investigated by Cox multifactor analysis.Results:In the early sedation ≤48 h after the start of mechanical ventilation, 63.2%(2 143/3 389) of patients with invasive mechanical ventilation had a RASS score of shallow sedation, 35.2%(1 194/3 389) of patients with deep sedation, and 1.5%(52/3 389) of patients with insufficient sedation. Cox multivariate regression analysis showed that age, sedation level, duration of invasive mechanical ventilation and continuous renal replacement therapy were the factors influencing the indentation time of tracheal insertion ( χ2 values were 4.73 to 74.31, all P<0.05); early deep sedation was a risk factor for delayed extubation ( HR=0.499, 95% CI 0.276-0.903, P<0.05); gender, sedation level, invasive mechanical ventilation duration, acute physiology and chronic health evaluation Ⅱ scores, admission mode, continuous renal replacement therapywere the influencing factors of patient outcomes ( χ2 values were 4.41 to 26.20, all P<0.05). The deeper the sedation, the worse the patient outcomes ( HR=0.568, 95% CI 0.335-0.963 all P<0.05) . Conclusions:The early sedation level is related to the retention time and outcome of tracheal intubation in ICU patients with mechanical ventilation, and different sedation levels affect the clinical outcome of patients. The retention time of tracheal intubation in patients with shallow sedation was shortened, which was beneficial to the outcome of patients.Therefore, sedation evaluation should be strengthened in clinical work, and sedation methods should be selected according to the needs of patients. In the absence of contraindications, the shallow sedation strategy should be implemented as soon as possible. This study provides some reference and theoretical basis for the formulation and management of clinical sedation strategies.

12.
Article in Chinese | WPRIM | ID: wpr-991908

ABSTRACT

Most hospitalized patients infected with coronavirus disease 2019 (COVID-19) are in severe or critical condition, and malnutrition is a key factor contributing to adverse outcomes. The basic principles of medical nutrition therapy have been determined in the recently released tenth edition of the National Diagnosis and Treatment Protocol. The principles have promoted nutritional risk assessment, emphasized the preferred method of enteral nutrition, and recommended the daily intake of calories at 25 to 30 kcal/kg and protein at > 1.2g/kg. Parenteral nutrition should be also added when necessary. Based on the above principles, Beijing Hospital has refined the medical nutrition therapy measures to facilitate the implementation in clinical practice, in order to improve healthcare quality and decrease the mortality in COVID-19 patients.

13.
Article in Chinese | WPRIM | ID: wpr-992120

ABSTRACT

Clinical high risk (CHR) is the prodrome stage of schizophrenia and the population with CHR show subtle clinical symptoms and abnormal brain structure and function. Specifically, the pathological changes in the brain were mainly manifested as reduced gray matter volume in the anterior cingulate gyrus and hippocampus, damaged white matter fibers in the corpus callosum, uncinate tract and arcuate tract, cerebellar atrophy, and abnormal resting-state brain network connection.This paper reviews the brain imaging features, their relationship with clinical symptoms, and their role in predicting clinical outcomes in individuals with CHR. In the future, we can combine artificial intelligence and neuroimaging techniques to find specific markers of brain structure and function in the CHR population to guide early clinical detection and intervention.

14.
Article in Chinese | WPRIM | ID: wpr-993217

ABSTRACT

Malnutrition is a common complication in patients with malignant tumors, which affects the clinical outcome of cancer patients. Accurate identification of malnutrition is the premise of nutritional intervention and treatment, but uniform diagnostic criteria for malnutrition are currently lacking. With the official release of the Global Leadership Initiative on Malnutrition (GLIM) initiated by global nutrition experts in 2018, a large cohort of studies have been carried out. In this article, the specific content and controversies of the GLIM criteria, its accuracy validation and clinical predictive value in patients with malignant tumors were mainly reviewed, aiming to provide reference for subsequent research and clinical application of malignant tumor-related malnutrition.

15.
East Cent Afr J Surg. ; 28(4): 1-6, 2023. figures, tables
Article in English | AIM | ID: biblio-1571197

ABSTRACT

Background: Open ureteric reimplantation is considered to be the gold standard treatment for numerous anomalies involving vesico-ureteric junction. The study was conducted to determine the outcome of ureteric reimplantation surgeries in terms of clinical and radiologic improvement. Methods: A retrospective cross-sectional study with a descriptive approach was implemented. All pediatric patients who underwent ureteric re-implantation surgery in Tikur Anbessa Hospital from September 1, 2015 to August 31, 2020 were included in the study. Data was collected using structured questionnaire from the patients' chart. Data was analysed using SPSS version 23. Patient characteristics, perioperative parameters, indications and outcomes of surgery studied. Results: A total of 36 including 5 bilateral ureteric reimplantation were done for 31 patients during the study period. Among these 20(64.5%) were male while the rest were female; with male to female ratio of 1.8:1. Age ranged from 4 months to 12 years with the mean age of 41 months. Cohen trans-trigonal ureteric reimplantation techniques used in 22(61.1%), including all bilateral cases, while Politano-Leadbetter and Lich-Gregoire repair techniques used in 11(30.5%) and 3(8.3%) respectively. Complication occurred in 2(6.5%) patients. Around 94 % had their symptoms resolved and showed improvement on the degree of hydronephrosis as evidenced on ultrasound scan done within 6 months of surgical intervention which was confirmed with late ultrasound. Conclusions: Pediatric open ureteric reimplantation is highly effective procedure in our setting. Ultrasound alone is found to be sufficient to follow the post-operative course of the disease in most patients without a need for other imaging studies.


Subject(s)
Humans , Male , Female , Replantation , General Surgery , Ureter , Ureteral Diseases , Cross-Sectional Studies , Tertiary Care Centers
16.
São Paulo med. j ; São Paulo med. j;140(4): 559-565, July-Aug. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1410192

ABSTRACT

ABSTRACT BACKGROUND: Acute kidney injury (AKI) is a frequent complication during the postoperative period following liver transplantation. Occurrence of AKI in intensive care unit (ICU) patients is associated with increased mortality and higher costs. OBJECTIVE: To evaluate occurrences of moderate or severe AKI among patients admitted to the ICU after liver transplantation and investigate characteristics associated with this complication. DESIGN AND SETTING: Single-center retrospective cohort study in a public hospital, Belo Horizonte, Brazil. METHODS: Forty-nine patients admitted to the ICU between January 2015 and April 2017 were included. AKI was defined from a modified Kidney Disease Improving Global Outcomes (KDIGO) score (i.e. based exclusively on serum creatinine levels). RESULTS: Eighteen patients (36.7%) developed AKI KDIGO 2 or 3; mostly KDIGO 3 (16 out of the 18 patients). Lactate level within the first six hours after ICU admission (odds ratio, OR: 1.3; 95% confidence interval, CI: 1.021-1.717; P = 0.034) and blood transfusion requirement within the first week following transplantation (OR: 8.4; 95% CI: 1.687-41.824; P = 0.009) were independently associated with development of AKI. Patients with AKI KDIGO 2 or 3 underwent more renal replacement therapy (72.2% versus 3.2%; P < 0.01), had longer hospital stay (20 days versus 15 days; P = 0.001), higher in-hospital mortality (44.4% versus 6.5%; P < 0.01) and higher mortality rate after one year (44.4% versus 9.7%; P = 0.01). CONCLUSION: Need for blood transfusion during ICU stay and hyperlactatemia within the first six postoperative hours after liver transplantation are independently associated with moderate or severe AKI. Developing AKI is apparently associated with poor outcomes.

17.
Article | IMSEAR | ID: sea-220249

ABSTRACT

Background: ST-Elevation myocardial infarction is a major public health problem and a leading cause of death both in developed and developing countries. The values of hematological biomarkers were evaluated as predictors of in hospital mortality and complications, in patients with acute coronary syndromes (ACS). This study aimed to draw a relationship between different hematological parameters and short-term clinical result in STEMI cases treated by primary percutaneous coronary intervention. Methods: This prospective research involved 100 participants that had a STEMI and were receiving primary PCI and they were subjected to detailed history, general and local examination, resting surface ECG, baseline laboratory tests, reperfusion, transthoracic echocardiogram and follow up of clinical outcome. Results: After STEMI, there was not significantly different between cases with low and high NLR (P <0.4). There was significantly different between cases with low and high NLR after STEMI, low and high MPV [in heart failure, death and rehospitalization] and after STEMI, in diabetic patients and in NLR between low and high MPV groups after STEMI (P < 0.05), there was no significant statistical difference between patients with low and high PDW and after STEMI. LVEF were significant less in participants had MACE (P <0.036). In stepwise multivariate regression analysis of hematological parameters, NLR and MPV were significant predictive factors of MACE (P < 0.05). Conclusions: Hematological and coagulation parameters may be utilized as diagnostic and prognostic indicators. Early risk classification enables doctors to closely monitor and treat high-risk patients, as well as schedule them for regular follow-ups, helping to the reduction of mortality.

18.
Article | IMSEAR | ID: sea-225776

ABSTRACT

Background: Coronavirus disease 2019 (COVID-19)has significant impact on the health infrastructure all over the world including India. We wanted to see whether the routine initial investigations done in COVID19 patients reflect the prognosis and outcome of the patient.Methods: It is a retrospective study involving the confirmed covid 19 patients admitted between April 2021 to May2021. The initial investigations done at the time of admission were studied in relation to outcome of the patient in the form of survival or death of the patient.Results: A total of 364 patients were studied. 295(81.05%) patients survived and 69(18.96%) patients died. Highest mortality was observed in 60% of patients with hemoglobinbelow 7.0mg/dl, 40.00% of patients with platelet count below 50000/cml, 28.80% with neutrophil lymphocyte ratio more than 5.5, 32.81% with CRP more than 100mg/L, 100% with D dimer more than 5000ng/ml, 33.33% with Ferritin more than 1500ng/ml, 29.54% with IL-6 more than 100pg/ml, 23.14% with Random blood sugar more than 200mg/dl, 37.50% with creatinine more than 2.0mg/dl, 75% with Bilirubin more than 2.0mg/dl, 42.85% with SGOT more than 201mg/dl, 22.22% with SGPT more than 201mg/dl, 38.46% with serum Procalcitonin more than 2.0mg/dl. CT Chest severity score of 21 to 30 and31 to 40 lead to mortality of 19.51% and 40.00% respectively. Conclusions: The physician who is taking care of COVID-19patients must get extra cautious regarding prognosis if he gets above initial parameters deranged in isolation or combination.

19.
Article | IMSEAR | ID: sea-217523

ABSTRACT

Background: COVID-19 pandemic quickly became significantly major cause of worldwide morbidity and mortality over the next years till date in an unforeseen manner. Aims and Objectives: Our study aims at unfolding the sociodemographic, epidemiological, and clinical characteristics of this disease, based on a metropolitan dedicated tertiary care hospital of India. Materials and Methods: Along with patient particulars, we recorded sociodemographic data, presenting symptoms, vital parameters, and blood parameters based on a pre-designed questionnaire, followed by complication analysis for 101 patients. Written consent was taken from each of the respondent before the interview and ethical approval was taken from Institution Ethics Committee (IEC) of Medical College and Hospital. [(Ref No. MC/KOL/IEC/Non-Spon/842/11/2020), Date- 5/11/2020]. Results: This study justified the trend of already available data such as median age of presentation (40–69 years), higher urban population (85.1%), higher rate of infection in health-care professionals (12.9%), and in patients with poor socioeconomic status. It revealed increased community transmission (74.3% with no definitive exposure), higher number of symptomatic cases admission (89.1%) with most common symptoms being fever (46%), shortness of breath (45%), sore throat (32%), and cough (26%). Hypertension (48%) and diabetes (34%) were major comorbidities in patients who were also proportionally more symptomatic and experienced more adverse effects compared to non-comorbid patients. A major chunk of the patients (46.53%) required some form of oxygen support for their treatment. Most common adverse effect was disseminated intravascular coagulation (23.76%) among which 67.74% had one or more comorbidities. We also reported slightly higher number of deaths (6.9%) compared to what other similar studies found. Conclusion: History of probable exposure was not a sole risk factor of acquiring infection, that is, community transmission was evident. Healthcare professionals were at high risk of getting infected, persons with comorbidity are at the highest risk of developing symptoms as well as complications.

20.
Indian J Ophthalmol ; 2022 Feb; 70(2): 472-476
Article | IMSEAR | ID: sea-224124

ABSTRACT

Purpose: To compare the clinicomicrobiological features and outcomes in patients with infectious endophthalmitis caused by biofilm?positive (BP) and biofilm?negative (BN) bacteria. Methods: This was a prospective, interventional, comparative, nonrandomized, consecutive case series. Culture?positive bacterial endophthalmitis cases from August 1, 2018 to July 31st 31, 2019 were included. All vitreous samples were tested for biofilm using crystal violet plate and XTT (2,3?bis?(2?methoxy?4?nitro?5?sulfophenyl)?2H?tetrazolium?5?carboxanilide) methods and classified as BN and BP. The antibiotic susceptibility of all organisms was determined. Anatomic and functional success was defined as intraocular pressure >5 mm Hg and final best?corrected vision ?20/400, respectively, at last visit. Results: There were 50 eyes in the BN group and 33 eyes in the BP group. BN group eyes required 2.86 ± 1.45 surgical interventions, and BP group eyes needed surgical 6.36 ± 2.89 interventions, P < 0.0001, 95% Confidence Interval, CI: 2–4. Median follow?up was 6 and 5 months, respectively (P = 0.33). Final logMAR vision was a median of 1.2 and 1.9 respectively; P = 0.0005, 95% C.I.: 0.4–1.7. Functional success was achieved in 44% and 21.2% (P = 0.03, 95% C.I.: 1.86%–40.08%) and anatomic success was achieved in 68% and 42.42%, respectively (P = 0.02, 95% C.I.: 3.85%–45.47%). The antimicrobial resistance patterns between the two groups were comparable. Conclusion: Endophthalmitis caused by the biofilm?forming bacteria needs a greater number of surgical interventions. The anatomic and functional outcomes are poorer than non?biofilm?forming bacterial endophthalmitis. The increased virulence and poorer outcomes can be hypothesized to be due to the physical barrier effect of the biofilm on the antibiotics

SELECTION OF CITATIONS
SEARCH DETAIL